Evidence map›Paper›PMID 33444460›Full record

ArticleAngewandte Chemie (International ed. in English)2021

Liquid Phase Peptide Synthesis via One-Pot Nanostar Sieving (PEPSTAR).

Jet Yeo, Ludmila Peeva, Seoyeon Chung, Piers Gaffney, Daeok Kim, Carla Luciani, Sergey Tsukanov, Kevin Seibert, Michael Kopach, Fernando Albericio and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Organic Solvent Nanofiltration in Pharmaceutical Applications.Organic process research & development · 2024
    Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Liquid Phase Peptide Synthesis via One-Pot Nanostar Sieving (PEPSTAR).Angewandte Chemie (International ed. in English) · 2021
    Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 4 countries.

Jet YeoBarrer Centre, Department of Chemical Engineering, Imperial College London, Exhibition Road, London, SW7 2AZ, UK.
Ludmila PeevaBarrer Centre, Department of Chemical Engineering, Imperial College London, Exhibition Road, London, SW7 2AZ, UK.
Seoyeon ChungBarrer Centre, Department of Chemical Engineering, Imperial College London, Exhibition Road, London, SW7 2AZ, UK.
Piers GaffneyBarrer Centre, Department of Chemical Engineering, Imperial College London, Exhibition Road, London, SW7 2AZ, UK.
Daeok KimBarrer Centre, Department of Chemical Engineering, Imperial College London, Exhibition Road, London, SW7 2AZ, UK.
Carla LucianiEli Lilly and Company, RNA-Therapeutics, 450 Kendal St, Cambridge, MA, 02142, USA.
Sergey TsukanovEli Lilly and Company, Synthetic Molecule Design & Development, 1200 W Morris St, Indianapolis, IN, 46221, USA.
Kevin SeibertEli Lilly and Company, Synthetic Molecule Design & Development, 1200 W Morris St, Indianapolis, IN, 46221, USA.
Michael KopachEli Lilly and Company, Synthetic Molecule Design & Development, 1200 W Morris St, Indianapolis, IN, 46221, USA.
Fernando AlbericioNetworking-Centre on Bioengineering, Biomaterials and Nanomedicine, Department of Organic Chemistry, University of Barcelona, Marti i Franques 1-11, 08028, Barcelona, Spain.
Andrew LivingstonBarrer Centre, Department of Chemical Engineering, Imperial College London, Exhibition Road, London, SW7 2AZ, UK.ORCID 0000-0003-0074-1426
Imperial College London · GBEli Lilly (United States) · USBiomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine · ESQueen Mary University of London · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Herein, a one-pot liquid phase peptide synthesis featuring iterative addition of amino acids to a "nanostar" support, with organic solvent nanofiltration (OSN) for isolation of the growing peptide after each synthesis cycle is reported. A cycle consists of coupling, Fmoc removal, then sieving out of the reaction by-products via nanofiltration in a reactor-separator, or synthesizer apparatus where no phase or material transfers are required between cycles. The three-armed and monodisperse nanostar facilitates both efficient nanofiltration and real-time reaction monitoring of each process cycle. This enabled the synthesis of peptides more efficiently while retaining the full benefits of liquid phase synthesis. PEPSTAR was validated initially with the synthesis of enkephalin-like model penta- and decapeptides, then octreotate amide and finally octreotate. The crude purities compared favorably to vendor produced samples from solid phase synthesis.

Indexed as

liquid phase peptide synthesismembranesorganic solvent nanofiltration (OSN)peptides

Identifiers

PMID33444460
PMCPMC8049079
OpenAlexW3121028134

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.